Satoshi Kidoguchi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Recent updates and perspectives in "Onco-hypertension".

Recent updates and perspectives in "Onco-hypertension".

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: March 24, 2026

The amount of sodium intake may affect the susceptibility to treatment with mineralocorticoid receptor antagonists in patients with primary aldosteronism.

The amount of sodium intake may affect the susceptibility to treatment with mineralocorticoid receptor antagonists in patients with primary aldosteronism.

Journal: Clinical and experimental nephrology

Published: February 21, 2026

SGLT2 inhibitor-induced glycosuria improves steatotic liver disease in parallel with enhanced ureagenesis in ob/ob mice.

SGLT2 inhibitor-induced glycosuria improves steatotic liver disease in parallel with enhanced ureagenesis in ob/ob mice.

Journal: Journal of pharmacological sciences

Published: October 21, 2025

Finerenone as an add-on treatment to conventional therapies for the patients with diabetic kidney disease.

Finerenone as an add-on treatment to conventional therapies for the patients with diabetic kidney disease.

Journal: BMC nephrology

Published: September 22, 2025

An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats.

An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats.

Journal: Diabetes, obesity & metabolism

Published: April 08, 2025

Is lenvatinib-induced blood pressure elevation a favorable prognostic factor in patients with hepatocellular carcinoma?

Is lenvatinib-induced blood pressure elevation a favorable prognostic factor in patients with hepatocellular carcinoma?

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: February 22, 2025

Bilateral or Unilateral Aldosterone Hypersecretion and Responsiveness to Therapy Are Associated with Differences in Calcium/Phosphate Homeostasis in Patients with Primary Aldosteronism.

Bilateral or Unilateral Aldosterone Hypersecretion and Responsiveness to Therapy Are Associated with Differences in Calcium/Phosphate Homeostasis in Patients with Primary Aldosteronism.

Journal: Internal medicine (Tokyo, Japan)

Published: February 25, 2024

Keratinocyte-specific angiotensin II receptor-associated protein deficiency exacerbates angiotensin II-dependent hypertension via activation of the skin renin-angiotensin system.

Keratinocyte-specific angiotensin II receptor-associated protein deficiency exacerbates angiotensin II-dependent hypertension via activation of the skin renin-angiotensin system.

Journal: Nature communications

Published: November 08, 2023

Blood pressure control with renin-angiotensin system inhibitors in hypertension patients with cancer - good or bad?

Blood pressure control with renin-angiotensin system inhibitors in hypertension patients with cancer - good or bad?

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: September 29, 2022

Contributions of renal water loss and skin water conservation to blood pressure elevation in spontaneously hypertensive rats.

Contributions of renal water loss and skin water conservation to blood pressure elevation in spontaneously hypertensive rats.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: July 12, 2022

Association of Antihypertensive Effects of Esaxerenone with the Internal Sodium Balance in Dahl Salt-Sensitive Hypertensive Rats.

Association of Antihypertensive Effects of Esaxerenone with the Internal Sodium Balance in Dahl Salt-Sensitive Hypertensive Rats.

Journal: International journal of molecular sciences

Published: June 29, 2022

Antihypertensive Drugs and Cancer Risk.

Antihypertensive Drugs and Cancer Risk.

Journal: American journal of hypertension

Published: February 14, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026